...
首页> 外文期刊>Diabetology and Metabolic Syndrome >Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: a cross-sectional study
【24h】

Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: a cross-sectional study

机译:一项横断面研究:日本成年男性中较高的血清可溶性受体可提高糖基化终产物水平,并降低代谢综合征的患病率

获取原文

摘要

Background Although several studies showed that decreased soluble receptor for advanced glycation end products (sRAGE) is associated with metabolic syndrome (MetS), inflammation level has not been considered, even though ligand–RAGE interaction induces inflammation. The objective of the study was to determine the association between sRAGE and MetS among Japanese adult in a cross-sectional survey, taking the level of low grade inflammation into consideration. Methods Serum soluble RAGE (sRAGE) were measured in 712 men and 176 women aged 30–83 years with serum C-reactive protein (hsCRP) concentration below 3 mg/L. MetS was defined using the criteria of the American Heart Association Scientific Statements of 2009. Results After multivariable adjustment, among men, higher sRAGE levels were associated with lower odds of MetS as well as central obesity and elevated blood pressure. Comparing the extreme tertiles of sRAGE, odds ratios (95% confidence interval) were 0.58 (0.36–0.95; P for trend?=?0.001) for MetS; 0.41 (0.25–0.52; P for trend?
机译:背景技术尽管一些研究表明,晚期糖基化终产物(sRAGE)的可溶性受体降低与代谢综合征(MetS)有关,但即使配体-RAGE相互作用引起炎症,也未考虑炎症水平。该研究的目的是在横断面调查中确定日本成年人中sRAGE与MetS之间的关联,同时考虑低度炎症的水平。方法对712名男性和176名30至83岁的女性血清C反应蛋白(hsCRP)浓度低于3 mg / L进行了测定。 MetS是根据2009年美国心脏协会科学声明的标准定义的。结果经过多变量调整后,男性中sRAGE水平升高与MetS几率降低,中枢肥胖和血压升高有关。比较sRAGE的极端三分位数,MetS的优势比(95%置信区间)为0.58(0.36-0.95;趋势P =?0.001)。中枢性肥胖为0.41(0.25-0.52; P为趋势?<0.001)?血压升高为0.45(0.29–0.70;趋势P <?0.001)。此外,根据参与者的中位hsCRP和sRAGE值对其进行分类。较高hsCRP /较高sRAGE类别的男性的MetS优势比较低hsCRP /较低sRAGE类别的男性的40%(P?=?0.031)。在女性中,sRAGE水平与MetS患病率之间没有关联。结论在日本男性中,较高的循环RAGE浓度与较低的MetS及其成分患病率有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号